Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Mitsubishi Heavy Industrial Develops New Cancer Treatment Device

This article was originally published in PharmAsia News

Executive Summary

Mitsubishi Heavy Industrial has developed a new X-ray cancer treatment device that scans and radiates affected areas. The equipment is jointly developed with Kyodo University and the Kobe-based Institute of Biomedical Research and Innovation and will be sold in Japan, the E.U. and the U.S. The device uses X-ray technology to scan cancer cells, processes information on the cancer position through computers, and then radiates the area with an oscillating X-ray head based on the processed information. Because of the high level of accuracy, Mitsubishi stated that the radiation therapy would reduce the occurrence of side effects and shorten treatment time. (Click here for more-Japanese language

Latest Headlines
See All
UsernamePublicRestriction

Register

SC067805

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel